EMD Serono is the U.S. healthcare business of Merck KGaA, Darmstadt, Germany - a global science and tech company with a legacy of using science as a force for good. We’re fueled for the future, leveraging our expertise to address unmet medical needs and impact the lives of patients who...
EMD Serono is the U.S. healthcare business of Merck KGaA, Darmstadt, Germany - a global science and tech company with a legacy of using science as a force for good. We’re fueled for the future, leveraging our expertise to address unmet medical needs and impact the lives of patients who...
使用说明-EMDSeronoInc 下载积分: 4000 内容提示: (注射用促卵泡激素α)皮下注射用处方药使用说明EMD Serono,Inc. 是德国达姆施塔特 Merck KGaA 的子公司300 IU / 0.5 mL 450 IU / 0.75 mL 300 IU / 0.5 mL 文档格式:PDF | 页数:50 | 浏览次数:50 | 上传日期:2017-08-30 02:40:58 | 文档星级: ...
Suresh Martha works at the intersection of two industries that are rapidly evolving with advancements in AI: business intelligence and biopharma/healthcare. He is the head of data-driven innovation and analytics at EMD Serono—the healthcare business of Merck KGaA, Darmstadt, Germany in the United...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
使用说明-EMDSeronoInc.PDF,(注射用促卵泡激素α) 300 IU / 0 .5 mL 450 IU / 0 .75 mL 300 IU / 0 .5 mL 皮下注射用 处方药 使用说明 EMD Serono ,Inc . 是德国达姆施塔特 Merck KGaA 的子公司 2 使用说明 GONAL-f® (果纳芬) RFF Redi-ject™ (注射用促卵泡激素α)
Merck KGaA subsidiary EMD Serono and Mersana Therapeutics announced that the companies have agreed to co-develop next-generation antibody-drug conjugates (ADCs). ADCs, which comprise an antibody linked to cytotoxic drugs, zero in on the cancer cells and deliver the cytotoxic drug to increase the ...
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
2/3,德国默克(Merck KGaA)旗下EMD Serono宣布,美国FDA已加速批准口服MET抑制剂Tepmetko(tepotinib)上市,用于治疗携带MET外显子14(METex14)跳跃变异的转移性非小细胞肺癌(NSCLC)成人患者。 Tepmetko是...
EMD Serono is dedicated to researching meaningful solutions for patients impacted by select endocrine disorders such as HIV-associated wasting.